Hi - does anyone's team routinely check mannitol vials in their ADC cabinets to see if there is crystallization?

Our organization is administering twice daily nasal decolonization with mupirocin for our adult patients admitted to a critical care unit. An order is built into our ICU admission and transfer orders to start 5 days of therapy.

If you are doing this, which presentation are you using (i.e., ointment vs cream).

Hello all,

Given the recent ISMP recommendation to align with ASPEN guidelines recommending a maximum hang-time of 12 hours for ILE, how has your organization handled the Epic/logistical dispensing aspect of switching lipids out at 12 hours? Any successes and/or pain points would be helpful!

Thanks,

Rachel

Looking to see if any sites are actively adding outpatient oncology treatment plans to patient's home med lists when completing admission medication reconciliation.

We utilize EPIC, and within our health network you can see if the patient is on an active therapy / treatment plan via the storyboard. Looking more specifically at patients that may receive oncology care outside of our health network and the best place to document when they last received their treatment, what the treatment is, etc.

Hello,

I am hoping to get insight on your experience with barcode scanning at omnicell dispense.

1. Has your institution activated bcma at adc dispense? (Ours is a meditech/omnicell system, soon to transition to epic)

2. if yes, do you have it turned on for specific meds only or all meds?

3. do you have a defined policy for this?

4. how did you go about operationalizing this? how did you decide which meds or drug classes to include?

I appreciate your help and input.

Greetings,

We are evaluating remifentanil for addition to formulary for OR cases where EEG monitoring would be used. Fentanyl and sufentanil are already on formulary and we do not have BCMA in procedural spaces.

For those with remifentanil in the OR, what safety strategies are you using?

Thanks,
Starr-Mar'ee Bedy

Hi all,
We have been notified that Bausch Health US is discontinuing production of this product used for urea cycle disorders. Does anyone know whether Zydis and Foshun brands are available in the US? I am in Canada so we would have to petition Canda's version of the FDA (Health Canada) for the product to be available in Canada.
Any leads would be greatly appreciated.
Have a great day,
Carol

Hello everyone! I'm an Advanced Practice Nurse and have been in healthcare for almost 40 years. I received my first Masters Degree (Nursing) in May 1995 and 30 years later, I'm on this journey to complete my 2nd Master's Degree (MJ in Health Law).

I'm on my final stretch here and working on my Thesis: Legal Implications of Medication Safety in US Hospitals and of which, my entire proposal is for mandating an MSO in every hospital.

As part of our Baxter IV fluid allocation, we have received two imports from Shanghai of normal saline 250mL bags. Import codes are A6C1322 (bag printed in Mandarin with no barcode), and A6C1322US (bag printed in English with barcode). When these bags were used to prepare hazardous medications using a closed system transfer device (CSTD) in the cleanroom, particulate matter was detected in the bag immediately after preparation. This occurred with two trials and so our health system plans to not use these bags with CSTDs.